Fundz

Fundz Deep Dive

Everything you need to win 60 Degrees Pharmaceuticals — in one platform.

Who to reach, what to say, and why now on 60 Degrees Pharmaceuticals — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on 60 Degrees Pharmaceuticals — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

60 Degrees Pharma Announces $1.075 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Feb 05, 2025over 1 year ago

Contract Type

partnership

WashingtonManufacturing

Description

60 Degrees Pharmaceuticals, Inc. has announced a registered direct offering priced at-the-market under Nasdaq rules. The company intends to use the net proceeds from the offering for working capital and other general corporate purposes.

Company Information

Company

60 Degrees Pharmaceuticals

Location

1025 CONNECTICUT AVENUE NW

Washington, District Of Columbia, United States

About

60 Degrees Pharmaceuticals, INC develops and commercializes new medicines to treat and prevent infectious diseases with a product focus on ARAKODA for malaria prevention, and a research focus on tickborne disease.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for 60 Degrees Pharmaceuticals's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.